Effect and its mechanism of "Shenxian Fuyuan Capsule" on the renal interstitial fibrosis of unilateral ureteral Obstruction rat model

张万超,马爱景,付平,谢席胜,何成奇

DOI: https://doi.org/10.3969/j.issn.1672-3511.2008.02.005

2008-01-01

Abstract:Objective To observe the therapeutic effect of "Shenxian Fuyuan Capsule"(SXFYC)on the renal interstitial fibrosis of unilateral ureteral obstruction(UUO)rat model,and then to study its possible mechanism.Methods Forty-eight Sprague-Dawley male rats were randomly divided into four groups:sham-operation group(SOR group),unilateral ureteral obstruction group(UUO group),losartan treatment group(LOS group)and SXFYC treatment group(SXFYC group).On the 7th day and 14th day after operation,we observed the pathologic change of the kidney and detected serum creatinine and proteinuria.The expression levels of TGF-β1(transforming growth factor-β1),α-SMA(α-smooth muscle actin),ColI(collagen I)and FN(fibronectin)were detected by immunohistochemistry and real-time polymerase chain reaction(RT-PCR)at each time point.Results On the 7th day and 14th day after operation,there was no significant difference in the level of proteinuria among groups at the same time point(P>0.05).The level of serum creatinine in UUO group was obviously higher than that in losartan treatment group and SXFYC treatment group(P<0.05).The damage of renal interstitium of UUO group was heavier than that of SXFYC and losartan treatment groups at the same time point(P<0.05)and there were no significant differences between the SXFYC and losartan t reatment groups(P>0.05).Immunohistochemistry and RT-PCR showed that the expression level of TGF-β1,α-SMA,ColI and FN in SXFYC and losartan treatment groups were lower than that in UUO group on the 7th day and 14th day after operation(P<0.05)and there were no significant differences between the SXFYC and losartan t reatment groups(P>0.05).Conclusion "Shenxian Fuyuan Capsule" can partly delay the progress of renal interstitial fibrosis in UUO rat model.Its mechamnism may be related to suppressing the expression of TGF-β1,α-SMA and reducing the composition of ColI and FN.